Advertisement
Screener

89bio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum

89bio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum

89bio, Inc. reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum of 86.80% for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-08.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum · last filed 2025-08-08

  • 89bio, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for the quarter ending 2025-03-31 was 86.80%, a 2.91% decline year-over-year.
  • 89bio, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for the quarter ending 2024-03-31 was 89.40%, a 2.40% decline year-over-year.
  • 89bio, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for the quarter ending 2023-03-31 was 91.60%, a 1.10% increase year-over-year.
  • 89bio, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for the quarter ending 2022-03-31 was 90.60%, a 7.08% decline year-over-year.
  • 89bio, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2024 was 85.90%, a 6.12% decline from fiscal 2023.
  • 89bio, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2023 was 91.50%, a 1.78% increase from fiscal 2022.
  • 89bio, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2022 was 89.90%, a 3.45% increase from fiscal 2021.
  • 89bio, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2021 was 86.90%, a 0.58% increase from fiscal 2020.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum 12 month
2025-06-3086.80%
10-Q · filed 2025-08-08
2025-03-3186.80%
10-Q · filed 2025-05-02
2024-12-3185.90%
10-K · filed 2025-02-27
2024-09-3086.50%
10-Q · filed 2024-11-07
2024-06-3087.30%
10-Q · filed 2025-08-08
2024-03-3189.40%
10-Q · filed 2025-05-02
2023-12-3191.50%
10-K · filed 2025-02-27
2023-09-3091.60%
10-Q · filed 2024-11-07
2023-06-3091.60%
10-Q · filed 2024-08-05
2023-03-3191.60%
10-Q · filed 2024-05-09
2022-12-3189.90%
10-K · filed 2025-02-27
2022-09-3089.90%
10-Q · filed 2023-11-09
2022-06-3089.90%
10-Q · filed 2023-08-09
2022-03-3190.60%
10-Q · filed 2023-05-08
2021-12-3186.90%
10-K · filed 2024-03-01
2021-09-3094.00%
10-Q · filed 2022-11-10
2021-06-3094.00%
10-Q · filed 2022-08-11
2021-03-3197.50%
10-Q · filed 2022-05-12
2020-12-3186.40%
10-K · filed 2022-03-24
2020-09-3086.40%
10-Q · filed 2021-11-12
2020-06-3086.40%
10-Q · filed 2021-08-13
2020-03-3186.40%
10-Q · filed 2021-05-14
2019-12-3161.80%
10-K · filed 2021-03-25
2019-09-3061.80%
10-Q · filed 2019-12-18